The Relationship between Metabolic Syndrome, Cardiometabolic Risk Factors and Inflammatory Markers in a Tehranian Population: The Tehran Lipid and Glucose Study

Internal Medicine

Volumn 51, Issue 24, 2012, Pages 3329-3335

  Zarkesh, Maryam ^a   Faam, Bita ^a   Daneshpour, Maryam Sadat ^a   Azizi, Fereidoun ^b   Hedayati, Mehdi ^a  

^a Shahid Beheshti University of Medical Sciences   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiometabolic risk factors; Inflammatory markers; Metabolic syndrome; TLGS

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HOMOCYSTEINE; INTERLEUKIN 6;

ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; FEMALE; HEART DISEASE; HUMAN; INFLAMMATION; IRAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; RISK FACTOR;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HEART DISEASES; HOMOCYSTEINE; HUMANS; INFLAMMATION; INTERLEUKIN-6; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 84878245810     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.8475     Document Type: Article

References (41)

1. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355: 763–778, 2006.
2. Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 20: 1057–1060, 2000.
3. He Y, Jiang B, Wang J, et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 47: 1588–1594, 2006.
4. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 105: 1135–1143, 2002.
5. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14,719 initially healthy American women. Circulation 107: 391–397, 2003.
6. Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM, Cruickshank K. C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups. Atherosclerosis 170: 79–86, 2003.
7. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 22: 1668–1673, 2002.
8. Woodward M, Rumley A, Tunstall-Pedoe H, Lowe GD. Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 104: 246–257, 1999.
9. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685–1695, 2005.
10. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128: 127–137, 1998.
11. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 325: 1202, 2002.
12. Agoston-Coldea L, Mocan T, Dobie L, Marginean A, Lupu S. The association between homocysteine level and metabolic syndrome in patients of prior myocardial infarction. Rom J Intern Med 48: 151–158, 2010.
13. Farhadi D. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337: 1632; author reply 1632–1633, 1997.
14. Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 10: 5, 2009.
15. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640–1645, 2009.
16. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 32: 1092–1097, 2009.
17. Azizi F Fau-Rahmani M, Rahmani M Fau-Emami H, Emami H Fau-Mirmiran P, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). 2002.
18. Azizi F Fau-Ghanbarian A, Ghanbarian A Fau-Momenan AA, Momenan AA Fau-Hadaegh F, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. 2009.
19. Festa A Fau-D’Agostino R Jr., D’Agostino R. Jr., Fau-Howard G., Howard G., Fau-Mykkanen L., Mykkanen L Fau-Tracy RP, Tracy Rp Fau-Haffner SM, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). 2000.
20. Devaraj S Fau-Rosenson RS, Rosenson RS Fau-Jialal I, Jialal I. Metabolic syndrome: An appraisal of the pro-inflammatory and procoagulant status. 2004.
21. Belfki H, Ben Ali S, Bougatef S, et al. Relationship of C-reactive protein with components of the metabolic syndrome in a Tunisian population. Eur J Intern Med 23: E5-e9, 2012.
22. Saiki O, Kuhara M, Kikuchi N, Shiraishi S, Uda H. Evaluation of lasting high levels of CRP among the patients with metabolic syndrome. Inflammation 35: 730–735, 2012.
23. Gobel RJ, Jensen SM, Frokiaer H, Molgaard C, Michaelsen KF. Obesity, inflammation and metabolic syndrome in Danish adolescents. Acta Paediatr 101: 192–200, 2012.
24. Cox BD Fau-Whichelow M, Whichelow M. Ratio of waist circumference to height is better predictor of death than body mass index. 1996.
25. Patel S, Unwin N, Bhopal R, et al. A comparison of proxy measures of abdominal obesity in Chinese, European and South Asian adults. Diabet Med 16: 853–860, 1999.
26. Hsieh SD, Yoshinaga H, Muto T, Sakurai Y, Kosaka K. Health risks among Japanese men with moderate body mass index. Int J Obes Relat Metab Disord 24: 358–362, 2000.
27. Hsieh SD, Yoshinaga H, Muto T. Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord 27: 610–616, 2003.
28. Sayeed MA, Mahtab H, Latif ZA, et al. Waist-to-height ratio is a better obesity index than body mass index and waist-to-hip ratio for predicting diabetes, hypertension and lipidemia. Bangladesh Med Res Counc Bull 29: 1–10, 2003.
29. Lin WY, Lee LT, Chen CY, et al. Optimal cut-off values for obesity: Using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord 26: 1232–1238, 2002.
30. De Nicola L, Conte G. Waist: Hip ratio is a better predictor of cardiovascular risk than BMI in patients with moderate CKD. Nat Clin Pract Nephrol 4: 592–593, 2008.
31. Pannu R, Snyder JE. Waist-hip ratio is a practical and valid predictor of CAD risk. ACP J Club 148: A9; author reply A9, 2008.
32. Henriksson KM, Lindblad U, Agren B, Nilsson-Ehle P, Rastam L. Associations between body height, body composition and cholesterol levels in middle-aged men. the coronary risk factor study in southern Sweden (CRISS). Eur J Epidemiol 17: 521–526, 2001.
33. Seidell JC, Han TS, Feskens EJ, Lean ME. Narrow hips and broad waist circumferences independently contribute to increased risk of non-insulin-dependent diabetes mellitus. J Intern Med 242: 401–406, 1997.
34. Snijder MB, Dekker JM, Visser M, et al. Larger thigh and hip circumferences are associated with better glucose tolerance: The Hoorn study. Obes Res 11: 104–111, 2003.
35. Allison DB, Zhu SK, Plankey M, Faith MS, Heo M. Differential associations of body mass index and adiposity with all-cause mortality among men in the first and second National Health and Nutrition Examination Surveys (NHANES I and NHANES II) follow-up studies. Int J Obes Relat Metab Disord 26: 410–416, 2002.
36. Shao J, Yu L, Shen X, Li D, Wang K. Waist-to-height ratio, an optimal predictor for obesity and metabolic syndrome in Chinese adults. J Nutr Health Aging 14: 782–785, 2010.
37. McNeill AM Fau-Rosamond WD, Rosamond WD Fau-Girman CJ, Girman CJ Fau-Golden SH, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. 2005.
38. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. 2005.
39. Taylor HA Jr, Fau-Wilson JG, Wilson JG Fau-Jones DW, Jones Dw Fau-Sarpong DF, et al. Toward resolution of cardiovascular health disparities in African Americans: Design and methods of the Jackson Heart Study. 2005.
40. Gyarfas I, Keltai M, Salim Y. [Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries in a case-control study based on the INTERHEART study]. Orv Hetil 147: 675–686, 2006 (in Hungarian, Abstract in English).
41. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: Systematic review and meta-analysis. Obes Rev 13: 275–286, 2012.